| Megan Boggs, PT, DPT | |
|
2400 13th St, Ashland, KY 41102-4510 | |
| (606) 329-0910 | |
| (606) 325-8434 |
| Full Name | Megan Boggs |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 2400 13th St, Ashland, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093186264 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Boggs, PT, DPT Po Box 1240, Ashland, KY 41105-1240 Ph: (606) 325-7955 | Megan Boggs, PT, DPT 2400 13th St, Ashland, KY 41102-4510 Ph: (606) 329-0910 |
News Archive
Now on Kaiser Health News' blog, Jay Hancock reports: "Filling a potential coverage void, Humana Inc. said Friday it will sell health insurance in 36 Mississippi counties that might have otherwise been left out of a marketplace for subsidized policies sold under the Affordable Care Act" (Hancock, 7/19).
Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which brain cells die following a stroke, as well as a possible way to mitigate that damage. The results of the study were recently published online in Nature Medicine.
Dr.Adi Gazdar, professor of pathology in the Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and senior author of the study in today's issue of the Journal of the National Cancer Institute, explains that the findings may show why certain lung cancer patients respond dramatically to a specific form of targeted therapy while others have little or no response.
While very little is known on the effects of immersive VR on adults, there is next to no knowledge on the impact of such systems on the sensorimotor abilities of young children.
Pfizer Inc. announced today top-line results from ORAL Start (A3921069), a Phase 3 study of the investigational agent tofacitinib, a novel, oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA).
› Verified 5 days ago
Mckenzie S Huffman, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2400 13th St, Ashland, KY 41102 Phone: 606-329-0910 Fax: 606-325-8434 | |
David Warren Apts, PT OCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2400 13th Street, Ashland, KY 41102 Phone: 606-329-0910 Fax: 606-325-9848 | |
Michael Lynn Thompson, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2400 13th Street, Ashland, KY 41102 Phone: 606-329-0910 Fax: 606-325-9848 | |
Kyle W Wessel, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2400 13th St, Ashland, KY 41102 Phone: 606-329-0910 Fax: 606-325-8434 | |
Todd E. Munson, PT, OCS Physical Therapist Medicare: Medicare Enrolled Practice Location: 2400 13th Street, Ashland, KY 41102 Phone: 606-329-0910 Fax: 606-325-9848 | |
Katrina Jean Rollins, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3100 Charles St, Ashland, KY 41102 Phone: 606-571-7676 |